Darrick Carter
55Patents
13h-index
56Co-inventors
87Inventor score
Filing activity: May 12, 2000 → Mar 21, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6800746B2 | Compositions and methods for the therapy and diagnosis of prostate cancer | Chemistry; Metallurgy | 39 | Expired |
| US6504010B1 | Compositions and methods for the therapy and diagnosis of lung cancer | Chemistry; Metallurgy | 27 | Expired |
| US6858204B2 | Compositions and methods for the therapy and diagnosis of lung cancer | Chemistry; Metallurgy | 25 | Expired |
| US9480740B2 | Synthetic glucopyranosyl lipid adjuvants | Human Necessities | 24 | Active |
| US8273361B2 | Vaccine composition containing synthetic adjuvant | Emerging Cross-Sectional Technologies | 24 | Active |
| US8343512B2 | Treatment of allergic conditions using a composition containing synthetic adjuvant | Emerging Cross-Sectional Technologies | 22 | Active |
| US8722064B2 | Synthetic glucopyranosyl lipid adjuvants | Human Necessities | 21 | Active |
| US6509448B2 | Compositions and methods for the therapy and diagnosis of lung cancer | Emerging Cross-Sectional Technologies | 20 | Expired |
| US8840908B2 | Vaccine composition containing synthetic adjuvant | Emerging Cross-Sectional Technologies | 19 | Active |
| US7574256B2 | Iontophoretic device and method of delivery of active agents to biological interface | Human Necessities | 18 | Active |
| US6746846B1 | Methods for diagnosing lung cancer | Chemistry; Metallurgy | 16 | Expired |
| US9907845B2 | Methods of using a vaccine composition containing synthetic adjuvant | Emerging Cross-Sectional Technologies | 14 | Active |
| US9950063B2 | Vaccine composition containing synthetic adjuvant | Emerging Cross-Sectional Technologies | 13 | Active |
| US6943236B2 | Compositions and methods for the therapy and diagnosis of prostate cancer | Chemistry; Metallurgy | 13 | Expired |
| US6620922B1 | Compositions and methods for the therapy and diagnosis of prostate cancer | Chemistry; Metallurgy | 10 | Expired |
| US6630305B1 | Compositions and methods for the therapy and diagnosis of prostate cancer | Chemistry; Metallurgy | 10 | Expired |
| US6699664B1 | Compositions and methods for the therapy and diagnosis of ovarian cancer | Chemistry; Metallurgy | 10 | Expired |
| US9987355B2 | Vaccine composition containing synthetic adjuvant | Emerging Cross-Sectional Technologies | 10 | Active |
| US11318213B2 | Compositions and methods for delivery of RNA | Emerging Cross-Sectional Technologies | 10 | Active |
| US6818751B1 | Compositions and methods for the therapy and diagnosis of prostate cancer | Chemistry; Metallurgy | 9 | Expired |
| US11458209B2 | Compositions and methods for delivery of nucleic acid-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigen | Emerging Cross-Sectional Technologies | 9 | Active |
| US11534497B2 | Compositions and methods for delivery of RNA | Emerging Cross-Sectional Technologies | 9 | Active |
| US11376335B2 | RNA-lipid nanoparticle complexes of viral RNA polymerase region and SARS-CoV-2 spike protein region | Emerging Cross-Sectional Technologies | 9 | Active |
| US11433142B2 | Compositions and methods for delivery of RNA-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigen | Emerging Cross-Sectional Technologies | 8 | Active |
| US6667154B1 | Compositions and methods for the therapy and diagnosis of lung cancer | Chemistry; Metallurgy | 8 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.